{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:09:48Z","timestamp":1795165788320,"version":"4.10.3"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2025,10,14]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Data from randomized clinical trials on a long-term anticoagulation strategy for patients after catheter-based ablation for atrial fibrillation (AF) are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether discontinuing oral anticoagulant therapy provides superior clinical outcomes compared with continuing oral anticoagulant therapy in patients without documented atrial arrhythmia recurrence after catheter ablation for AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>\n                      A randomized clinical trial including 840 adult patients (aged 19-80 years) who were enrolled and randomized from July 28, 2020, to March 9, 2023, at 18 hospitals in South Korea. Enrolled patients had at least 1 non\u2013sex-related stroke risk factor (determined using the CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score [range, 0-9]) and no documented recurrence of atrial arrhythmia for at least 1 year after catheter ablation for AF. The CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score is used as an assessment of stroke risk among patients with AF (calculated using point values for congestive heart failure, hypertension, \u226575 years of age, diabetes, stroke or transient ischemic attack, vascular disease, between 65 and 74 years of age, and sex category). The date of final follow-up was June 4, 2025.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>The patients were randomly assigned in a 1:1 ratio to discontinue oral anticoagulant therapy (n\u2009=\u2009417) or continue oral anticoagulant therapy (with direct oral anticoagulants; n\u2009=\u2009423).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the first occurrence of a composite of stroke, systemic embolism, and major bleeding at 2 years. Individual components of the primary outcome (such as ischemic stroke and major bleeding) were assessed as secondary outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 840 adults randomized, the mean age was 64 (SD, 8) years, 24.9% were women, the mean CHA\n                      <jats:sub>2<\/jats:sub>\n                      DS\n                      <jats:sub>2<\/jats:sub>\n                      -VASc score was 2.1 (SD, 1.0), and 67.6% had paroxysmal AF. At 2 years, the primary outcome occurred in 1 patient (0.3%) in the discontinue oral anticoagulant therapy group vs 8 patients (2.2%) in the continue oral anticoagulant therapy group (absolute difference, \u20131.9 percentage points [95% CI, \u22123.5 to \u22120.3];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.02). The 2-year cumulative incidence of ischemic stroke was 0.3% in the discontinue oral anticoagulant therapy group vs 0.8% in the continue oral anticoagulant therapy group (absolute difference, \u22120.5 percentage points [95% CI, \u22121.6 to 0.6]). Major bleeding occurred in 0 patients in the discontinue oral anticoagulant therapy group vs 5 patients (1.4%) in the continue oral anticoagulant therapy group (absolute difference, \u20131.4 percentage points [95% CI, \u22122.6 to \u22120.2]).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>Among patients without documented atrial arrhythmia recurrence after catheter ablation for AF, discontinuing oral anticoagulant therapy resulted in a lower risk for the composite outcome of stroke, systemic embolism, and major bleeding vs continuing direct oral anticoagulant therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/study\/NCT04432220?id=NCT04432220&amp;amp;amp;rank=1\">NCT04432220<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jama.2025.14679","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T16:30:16Z","timestamp":1756657816000},"page":"1246","source":"Crossref","is-referenced-by-count":125,"title":["Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation"],"prefix":"10.1001","volume":"334","author":[{"given":"Daehoon","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemin","family":"Shim","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Korea University Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Young","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Seoul National University Bundang Hospital, Seongnam, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"Heart Institute, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Daegu Catholic University Hospital, Daegu, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbeom","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ewha Womans University Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jum-Suk","family":"Ko","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Wonkwang University School of Medicine and Hospital, Iksan, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Min","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hoon","family":"Sung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Wook","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Seob","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Keimyung University Hospital, Daegu, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Woon","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Chung-Ang University Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Kyu","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hanyang University Seoul Hospital, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyeok","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Inha University College of Medicine and Inha University Hospital, Incheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Kyung Hee University Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Tae","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sun","family":"Uhm","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Nam","family":"Pak","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ALONE-AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sun","family":"Uhm","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Tae","family":"Yu","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daehoon","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjin","family":"Park","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemin","family":"Shim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il-Young","family":"Oh","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Joon","family":"Choi","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gi-Byoung","family":"Nam","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Soo","family":"Cho","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbeom","family":"Park","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jum-Suk","family":"Ko","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung-Min","family":"Park","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hoon","family":"Sung","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Wook","family":"Park","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoung-Seob","family":"Park","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JongMin","family":"Hwang","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Wan","family":"Chung","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Woon","family":"Kang","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmin","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Kyu","family":"Park","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyeok","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Soo","family":"Baek","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Bae","family":"Kim","sequence":"additional","affiliation":[{"name":"for the ALONE-AF Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"joi250063r1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation.","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"issue":"36","key":"joi250063r2","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"24","key":"joi250063r3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1136\/heartjnl-2017-312930","article-title":"Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015.","volume":"104","author":"Kim","year":"2018","journal-title":"Heart"},{"key":"joi250063r4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ahj.2018.04.017","article-title":"10-Year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population.","volume":"202","author":"Kim","year":"2018","journal-title":"Am Heart J"},{"issue":"13","key":"joi250063r5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation.","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"issue":"13","key":"joi250063r6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation.","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"14","key":"joi250063r7","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation.","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"joi250063r8","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation.","volume":"26","author":"Tzeis","year":"2024","journal-title":"EP Europace"},{"issue":"3","key":"joi250063r9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10840-013-9835-1","article-title":"Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes.","volume":"38","author":"Winkle","year":"2013","journal-title":"J Interv Card Electrophysiol"},{"issue":"7","key":"joi250063r10","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/europace\/eut406","article-title":"Incidence of cerebral thromboembolic events during long-term follow-up in patients treated with transcatheter ablation for atrial fibrillation.","volume":"16","author":"Gaita","year":"2014","journal-title":"Europace"},{"issue":"1","key":"joi250063r11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/HCO.0000000000000121","article-title":"Long-term oral anticoagulation for patients after successful catheter ablation of atrial fibrillation.","volume":"30","author":"Ha","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"7","key":"joi250063r12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/eurheartj\/ehad798","article-title":"Oral anticoagulation after atrial fibrillation catheter ablation.","volume":"45","author":"Kanaoka","year":"2024","journal-title":"Eur Heart J"},{"issue":"16","key":"joi250063r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e36506","article-title":"The Anticoagulation One year after Ablation of Atrial Fibrillation in Patients with Atrial Fibrillation (ALONE-AF) trial.","volume":"10","author":"Kim","year":"2024","journal-title":"Heliyon"},{"issue":"11","key":"joi250063r14","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation.","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"joi250063r15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"joi250063r16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","article-title":"Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.","volume":"159","author":"ROCKET AF Study Investigators","year":"2010","journal-title":"Am Heart J"},{"issue":"1","key":"joi250063r17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"11","key":"joi250063r18","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients.","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"5","key":"joi250063r19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/eurheartj\/ehu421","article-title":"Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding.","volume":"36","author":"Karasoy","year":"2015","journal-title":"Eur Heart J"},{"issue":"12","key":"joi250063r20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"joi250063r21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation.","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"31","key":"joi250063r22","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1093\/eurheartj\/ehw087","article-title":"Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death.","volume":"37","author":"Friberg","year":"2016","journal-title":"Eur Heart J"},{"issue":"9","key":"joi250063r23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007414","article-title":"Catheter ablation versus medical therapy for atrial fibrillation.","volume":"12","author":"Asad","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"joi250063r24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002597","article-title":"Patterns of anticoagulation use and cardioembolic risk after catheter ablation for atrial fibrillation.","volume":"4","author":"Noseworthy","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"joi250063r25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation.","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"issue":"13","key":"joi250063r26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes.","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"joi250063r27","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation.","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"joi250063r28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1001\/jamainternmed.2013.1561","article-title":"Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF).","volume":"173","author":"Verma","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"1","key":"joi250063r29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.121.056109","article-title":"Influence of monitoring strategy on assessment of ablation success and postablation atrial fibrillation burden assessment.","volume":"145","author":"Aguilar","year":"2022","journal-title":"Circulation"},{"key":"joi250063r30","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2025.05.040","article-title":"East Asian immigration and direct oral anticoagulant dosing for atrial fibrillation.","author":"Nakajima","journal-title":"Heart Rhythm"},{"issue":"19","key":"joi250063r31","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/eurheartj\/ehy776","article-title":"Stroke prevention in AF.","volume":"40","author":"Steffel","year":"2019","journal-title":"Eur Heart J"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2838294\/jama_kim_2025_oi_250063_1759505027.48261.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T15:03:17Z","timestamp":1760454197000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2838294"}},"subtitle":["The ALONE-AF Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":31,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2025.14679","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}